2025-02-08 - Analysis Report
## Starbucks Corp (SBUX) Stock Performance Review

**0. Summary of Key Figures:**

* **Cumulative Return (SBUX):** 74.75%
* **Cumulative Return (VOO):** 120.63%
* **Return Difference (SBUX vs VOO):** -45.9%
* **Relative Divergence:** 34.0% (indicates SBUX underperformed VOO, but within the historical range of its performance relative to VOO)
* **Current Price:** $111.69
* **RSI:** 90.14 (Overbought)
* **PPO:** 1.34 (Positive, suggesting upward momentum)
* **20-day Relative Divergence Change:** +2.8% (Short-term upward trend)
* **Expected Return (long-term, vs. S&P 500):** -28.4%


**1. Performance Comparison (SBUX vs. VOO):**

Starbucks Corp is a global coffeehouse chain.  Over the period analyzed, SBUX exhibited a cumulative return of 74.75%, significantly lagging the S&P 500 (VOO) which achieved 120.63%.  The difference of -45.9% highlights underperformance. While this sounds significant, the relative divergence of 34.0% suggests that this level of underperformance is not entirely unusual historically relative to the S&P 500, given the maximum and minimum divergence in the past.  Further analysis of the provided alpha and beta is required to fully interpret this performance gap.


**Alpha and Beta Analysis:**

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2015-2017  | -1.0% | 5.8% | -29.0% | 0.0 | 56.0 |
| 2016-2018  | 2.0% | 11.9% | -17.0% | 0.3 | 64.3 |
| 2017-2019  | 54.0% | 11.9% | 23.0% | 1.2 | 89.4 |
| 2018-2020  | 79.0% | 15.3% | 52.0% | 1.0 | 111.1 |
| 2019-2021  | 64.0% | 15.3% | -7.0% | 1.0 | 123.5 |
| 2020-2022  | 9.0% | 17.4% | 0.0% | 1.0 | 107.2 |
| 2021-2023  | -16.0% | 17.4% | -39.0% | 1.4 | 105.9 |
| 2022-2024  | -17.0% | 17.4% | -50.0% | 1.5 | 103.3 |
| 2023-2025  | -1.0% | 13.7% | -63.0% | 1.1 | 126.5 |

The alpha values show periods of significant outperformance (positive alpha) and underperformance (negative alpha) relative to the market. Beta is consistently above 1, indicating higher volatility than the market.


**2. Recent Price Movements:**

* **Closing Price:** $111.70
* **Last Market Price:** $111.32 (Slight decrease of -$0.38)
* **5-day Moving Average:** $110.08
* **20-day Moving Average:** $100.75
* **60-day Moving Average:** $97.87

The price is above all three moving averages, suggesting a short-term upward trend.


**3. Technical Indicators:**

* **RSI (90.14):**  Indicates the stock is significantly overbought, suggesting a potential pullback.
* **PPO (1.34):** Positive value suggests upward momentum.
* **20-day Relative Divergence Change (+2.8%):**  Confirms a short-term upward trend.
* **Expected Return (-28.4%):**  Projects significant underperformance relative to the S&P 500 over the long term (2+ years).  This is concerning.


**4. Recent Earnings Analysis:**

| Date       | EPS   | Revenue     |
|------------|-------|-------------|
| 2025-01-28 | $0.69 | $9.40B      |
| 2024-07-30 | $0.93 | $9.11B      |
| 2024-04-30 | $0.68 | $8.56B      |
| 2024-01-30 | $0.90 | $9.43B      |
| 2025-01-28 | $0.90 | $9.43B      | *(Note: This appears to be a duplicate entry)*

Earnings show some volatility with inconsistent EPS and revenue figures. More data is needed for comprehensive analysis.  The duplicate entry needs clarification.


**5. Financial Information:**

**Revenue and Profitability:**

| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2024-12-31 | $9.40B | 24.49% |
| 2024-09-30 | $9.07B | 26.25% |
| 2024-06-30 | $9.11B | 27.91% |
| 2024-03-31 | $8.56B | 25.58% |
| 2023-12-31 | $9.43B | 27.51% |

Revenue is relatively stable, but profit margins fluctuate.

**Capital and Profitability:**

| Quarter | Equity | ROE |
|---------|---------|-----|
| 2024-12-31 | $-7.47B | -10.45% |
| 2024-09-30 | $-7.45B | -12.21% |
| 2024-06-30 | $-7.95B | -13.28% |
| 2024-03-31 | $-8.45B | -9.14% |
| 2023-12-31 | $-8.62B | -11.89% |

Negative equity and ROE are very concerning and indicate significant financial challenges. This needs further investigation.


**6. Overall Analysis:**

SBUX has shown significant underperformance compared to the S&P 500. While short-term technical indicators suggest upward momentum, the overbought RSI and the negative long-term expected return signal caution.  The negative equity and ROE from the financial statements raise serious concerns about the company's financial health.  Before considering any investment, a thorough investigation into the reasons behind the negative equity and ROE, along with clarification on the duplicated earnings data is crucial.  The current data suggests significant risk.
